North America Breast Lesion Localization Methods Market: By Technology (Radio Isotope Localization (Radio Isotope Seed Localization (RSL), Radio Occult Lesion Localization (ROLL), Others), Wire Guided localization, Magnetic Tracker, Others), By End User (Hospitals, Ambulatory Surgical Centers (ASC’s), and Others) and Geography  

Purchase Option

$ 3000
$ 4400
$ 4600
$ 6900

Breast cancer is characterized by the abnormal multiplication of the breast cells that will form lumps, which may be nonmalignant or malignant in nature. Such abnormal breast cells usually form tumors, which may often observe on x-ray. Breast cancer occurs commonly in woman above 40 years of age and often it can be seen in men also. For the early detection of the lumps or lesions, various methods are used. Breast lesion localization methods are used to detect the nonpalatable suspicious breast lesions during the biopsy. Breast lesion localization procedures are used to locate abnormalities in the breasts, such as a lump or tumour. Breast lumps are common among women of all ages. The surgeon must choose an appropriate localization method based on a variety of considerations, including the patient's average age, the length of the procedure, its effectiveness, the cost of surgery, its safety, and its convenience of use.

North America Breast Lesion Localization Methods Market Summary

Study Period

2021 2027

Base Year




Largest Market


Fastest Growing Market

North America Breast Lesion Localization Methods Market Dynamics

North America breast lesion localization methods market is mainly driven prevalence rates of the breast cancers and technological advancements in the region. In addition, favorable health and reimbursement policies coupled with the rise in awareness of early detection of breast cancer projected to bolster the market growth further. Furthermore, recent U.S. launch of the innovative products and well established healthcare infrastructure in U.S. and Canada projected to boost the North America breast lesion localization market over the forecast period. However, stringent regulatory requirements and high cost of diagnosis projected to hamper the market share over the coming years.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

North America Breast Lesion Localization Methods Market Segmentation

By Technology
  • Radio Isotope Localization
    • Radio Isotope Seed Localization (RSL)
    • Radio Occult Lesion Localization (ROLL)
    • Others
  • Wire Guided localization
  • Magnetic Tracker
  • Others
By End-User
  • Hospitals
  • Ambulatory Surgical Centers (ASC’s)
  • Others


Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

[urltag url='request-table-of-content']

  • Cianna Medical, Inc. (U.S.)
  • STERYLAB (Italy)
  • Cook Group Inc. (U.S.)
  • SOMATEX Medical Technologies GmbH (Germany)
  • CP Medical, Inc. (Theragenics Corporation) (U.S.)
  • R. Bard, Inc. (U.S.)
  • Argon Medical Devices, Inc. (ACI Medical Devices, Inc.) (U.S.)
  • Faxitron, Inc. (Faxitron Bioptics, LLC) (U.S.)
  • Endomag (U.K.)